Intervention Protocol

Paediatric Formulations of Artemisinin-Combination Therapies for Treating Uncomplicated Malaria in Children

  1. Sabine Bélard2,
  2. Florian Kurth3,
  3. Michael Ramharter1,*

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 18 JAN 2012

DOI: 10.1002/14651858.CD009568


How to Cite

Bélard S, Kurth F, Ramharter M. Paediatric Formulations of Artemisinin-Combination Therapies for Treating Uncomplicated Malaria in Children (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD009568. DOI: 10.1002/14651858.CD009568.

Author Information

  1. 1

    Medical University of Vienna, Vienna, Austria

  2. 2

    University of Freiburg, Centre for Paediatrics and Adolescent Medicine, Freiburg, Germany

  3. 3

    Charité Universitätsmedizin Berlin, Department of Infectious Diseases and Pulmonnary Medicine, Berlin, Germany

*Michael Ramharter, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, 1190, Austria. michael.ramharter@meduniwien.ac.at.

Publication History

  1. Publication Status: New
  2. Published Online: 18 JAN 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this systematic review is to assess the effects of paediatric fixed-dose ACT compared to non-paediatric ACT in the treatment of uncomplicated P. falciparum malaria in children up to 14 years old.

Specific objectives are:

  1. To assess the efficacy of paediatric fixed-dose ACT compared to non-paediatric ACT for treating uncomplicated P. falciparum malaria in children up to 14 years old.
  2. To assess the safety and tolerability of paediatric fixed-dose ACT compared to non-paediatric ACT for treating uncomplicated P. falciparum malaria in children up to 14 years old.
  3. To assess the acceptability of paediatric fixed-dose ACT compared to non-paediatric ACT for treating uncomplicated P. falciparum malaria in children up to 14 years old.